Epidemiology of preeclampsia: impact of obesity.

Preeclampsia is a pregnancy-specific disorder that affects 2-8% of all pregnancies and remains a leading cause of maternal and perinatal morbidity and mortality worldwide. Diagnosis is based on new onset of hypertension and proteinuria. Multiple organ systems can be affected, with severe disease resulting. The wide range of risk factors reflects the heterogeneity of preeclampsia. Obesity, which is increasing at an alarming rate, is also a risk factor for preeclampsia as well as for later-life cardiovascular disease. Exploring common features may provide insight into the pathophysiologic mechanisms underlying preeclampsia among obese and overweight women.

[1]  M. Lindheimer,et al.  Chesley's Hypertensive Disorders in Pregnancy , 2009 .

[2]  R. Romero,et al.  Maternal serum adiponectin multimers in preeclampsia , 2009, Journal of perinatal medicine.

[3]  Lucinda J England,et al.  Smoking and risk of preeclampsia: a systematic review. , 2007, Frontiers in bioscience : a journal and virtual library.

[4]  C. Berg,et al.  Overview of Maternal Morbidity During Hospitalization for Labor and Delivery in the United States: 1993–1997 and 2001–2005 , 2009, Obstetrics and gynecology.

[5]  Anne B Wallis,et al.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. , 2008, American journal of hypertension.

[6]  B. Sibai,et al.  Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. , 1991, American journal of obstetrics and gynecology.

[7]  K. Joseph,et al.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[8]  J. Strauss,et al.  Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medicalfood on pre-eclampsia in high risk population : Randomised controlled trial , 2019 .

[9]  R. T. Lie,et al.  Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.

[10]  R. Ness,et al.  Risk of early or severe pre-eclampsia related to pre-existing conditions. , 2007, International journal of epidemiology.

[11]  H. Koistinen,et al.  Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. , 2000, Metabolism: clinical and experimental.

[12]  S. Cnattingius,et al.  Tobacco Use During Pregnancy and Preeclampsia Risk: Effects of Cigarette Smoking and Snuff , 2010, Hypertension.

[13]  B. G. Pereira,et al.  Pregnancy after bariatric surgery: a current view of maternal, obstetrical and perinatal challenges , 2012, Archives of Gynecology and Obstetrics.

[14]  B. Sibai,et al.  Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 2000, American journal of obstetrics and gynecology.

[15]  R. Grimble.  Inflammatory status and insulin resistance , 2002, Current opinion in clinical nutrition and metabolic care.

[16]  R. Ness,et al.  Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia. , 2008, American journal of hypertension.

[17]  K. Hecher,et al.  The Role of Nitric Oxide Synthase Inhibition by Asymmetric Dimethylarginine in the Pathophysiology of Preeclampsia , 2009, Gynecologic and Obstetric Investigation.

[18]  Y. Taketani,et al.  Selective increase in high molecular weight adiponectin concentration in serum of women with preeclampsia. , 2007, Journal of reproductive immunology.

[19]  R. Ness,et al.  Free leptin is increased in normal pregnancy and further increased in preeclampsia. , 2000, Metabolism: clinical and experimental.

[20]  James M. Roberts,et al.  Preeclampsia: recent insights. , 2005, Hypertension.

[21]  K. Conrad,et al.  Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.

[22]  S. Karumanchi,et al.  Midpregnancy levels of angiogenic markers in relation to maternal characteristics. , 2011, American journal of obstetrics and gynecology.

[23]  James J. Walker,et al.  Pre-eclampsia , 2000, The Lancet.

[24]  W. Ferrell,et al.  Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. , 2007, The Journal of clinical endocrinology and metabolism.

[25]  C. Best,et al.  The recurrence risk of severe de novo pre‐eclampsia in singleton pregnancies: a population‐based cohort , 2009, BJOG : an international journal of obstetrics and gynaecology.

[26]  S. Founds,et al.  A Comparison of Circulating TNF-α in Obese and Lean Women with and without Preeclampsia , 2008, Hypertension in pregnancy.

[27]  D. Malaspina,et al.  Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem perinatal study. , 2005, Paediatric and perinatal epidemiology.

[28]  R. Ness,et al.  Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. , 2005, American journal of epidemiology.

[29]  A. Aljada,et al.  Contemporary Reviews in Cardiovascular Medicine Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation , 2022 .

[30]  R. Kaaja.  Insulin Resistance Syndrome in Preeclampsia , 1998, Seminars in reproductive endocrinology.

[31]  Kirsten Duckitt,et al.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.

[32]  S. Hernández-Díaz,et al.  Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study , 2009, BMJ : British Medical Journal.

[33]  B. Sibai,et al.  Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 2000, American journal of obstetrics and gynecology.

[34]  U. Hanson,et al.  Outcome of Pregnancies Complicated by Type 1 Insulin-Dependent Diabetes in Sweden: Acute Pregnancy Complications, Neonatal Mortality and Morbidity , 1993, American journal of perinatology.

[35]  M. Williams,et al.  Preeclampsia. A nested, case-control study of risk factors and their interactions. , 1996, The Journal of reproductive medicine.

[36]  K. Lim,et al.  Circulating angiogenic factors and the risk of preeclampsia. , 2004, The New England journal of medicine.

[37]  S. Yusuf,et al.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. , 2008, American heart journal.

[38]  G. Woelk,et al.  Risk factors for pre-eclampsia among Zimbabwean women: maternal arm circumference and other anthropometric measures of obesity. , 1998, Paediatric and perinatal epidemiology.

[39]  D. Rouse,et al.  Prevention of premature birth. , 1998, The New England journal of medicine.

[40]  R. Ness,et al.  Chapter 3 – Epidemiology of Pregnancy-Related Hypertension , 2009 .

[41]  B. Sibai,et al.  Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1995, American journal of obstetrics and gynecology.

[42]  R. Berkowitz,et al.  Pregnancy Outcome at Age 40 and Older , 1996, Obstetrics and gynecology.

[43]  T. Hulsey,et al.  Revisiting the epidemiological standard of preeclampsia: primigravidity or primipaternity? , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[44]  R. Resnik,et al.  Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice , 2013 .

[45]  L. Poston,et al.  A longitudinal study of biochemical variables in women at risk of preeclampsia. , 2002, American journal of obstetrics and gynecology.

[46]  P. Catalano,et al.  Pregnancy and obesity. , 2009, Obstetrics and gynecology clinics of North America.

[47]  F. Facchinetti,et al.  Clinical use of nitric oxide donors and l-arginine in obstetrics , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[48]  H. Arnesen,et al.  Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. , 2004, Metabolism: clinical and experimental.

[49]  Y. Friedlander,et al.  Long-Term Mortality After Preeclampsia , 2005, Epidemiology.

[50]  R. Schrier.  Renal and Electrolyte Disorders , 1976 .

[51]  A. Peaceman,et al.  Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. , 1994, American journal of obstetrics and gynecology.

[52]  L. Chesley,et al.  The remote prognosis of eclamptic women. , 1976, American heart journal.

[53]  G. Bonsel,et al.  Risk Factors for Preeclampsia in Nulliparous Women in Distinct Ethnic Groups: A Prospective Cohort Study , 1998, Obstetrics and gynecology.

[54]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[55]  M. Fasshauer,et al.  Serum levels of the adipokine visfatin are increased in pre‐eclampsia , 2008, Clinical endocrinology.

[56]  Benjamin Caballero,et al.  Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic , 2008, Obesity.

[57]  V. Steinthorsdottir,et al.  Recurrence of hypertensive disorder in second pregnancy. , 2006, American journal of obstetrics and gynecology.

[58]  R. Ness,et al.  Prepregnancy Body Mass Index and the Occurrence of Severe Hypertensive Disorders of Pregnancy , 2007, Epidemiology.

[59]  L. Chasan-Taber,et al.  Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women. , 2009, American journal of obstetrics and gynecology.

[60]  L. Bodnar,et al.  The Role of Obesity in Preeclampsia. , 2011, Pregnancy hypertension.

[61]  C. Hubel,et al.  Is oxidative stress the link in the two-stage model of pre-eclampsia? , 1999, The Lancet.

[62]  B. Sibai,et al.  Low-dose aspirin to prevent preeclampsia in women at high risk , 1998 .

[63]  J. Hutcheon,et al.  Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model , 2011, The Lancet.

[64]  James M. Roberts,et al.  Elevated asymmetric dimethylarginine concentrations precede clinical preeclampsia, but not pregnancies with small-for-gestational-age infants. , 2008, American journal of obstetrics and gynecology.

[65]  Lelia Duley,et al.  The global impact of pre-eclampsia and eclampsia. , 2009, Seminars in perinatology.

[66]  Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic Hypertension , 1998 .

[67]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[68]  C. Redman,et al.  Immunology of preeclampsia. , 1991, Seminars in perinatology.

[69]  S. Bode-Böger,et al.  Asymmetric Dimethylarginine, Derangements of the Endothelial Nitric Oxide Synthase Pathway, and Cardiovascular Diseases , 2000, Seminars in thrombosis and hemostasis.

[70]  James M. Roberts,et al.  Pregnancy-Related Hypertension , 2009 .

[71]  B Gullberg,et al.  Serum concentrations of beta-carotene and alpha-tocopherol are associated with diet, smoking, and general and central adiposity. , 2001, The American journal of clinical nutrition.

[72]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[73]  R. Ness,et al.  The risk of preeclampsia rises with increasing prepregnancy body mass index. , 2005, Annals of epidemiology.

[74]  B. Sibai,et al.  Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. , 1997, American journal of obstetrics and gynecology.

[75]  M. Wolf,et al.  Obesity and preeclampsia: the potential role of inflammation. , 2001 .

[76]  Roberta B. Ness,et al.  Epidemiology of Pregnancy-Related Hypertension , 2015 .

[77]  B. Sibai,et al.  The Effect of Fetal Number on the Development of Hypertensive Conditions of Pregnancy , 2005, Obstetrics and gynecology.

[78]  T. Vik,et al.  Prepregnancy weight status and the risk of adverse pregnancy outcome , 2008, Acta obstetricia et gynecologica Scandinavica.

[79]  E. Rey,et al.  The prognosis of pregnancy in women with chronic hypertension. , 1994, American journal of obstetrics and gynecology.

[80]  R. Hoover,et al.  Maternal angiogenic profile in pregnancies that remain normotensive. , 2011, European journal of obstetrics, gynecology, and reproductive biology.

[81]  L. Chesley,et al.  The remote prognosis of eclamptic women. Sixth periodic report. , 1976, American journal of obstetrics and gynecology.

[82]  M. Wolzt,et al.  Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. , 2004, The Journal of clinical endocrinology and metabolism.

[83]  A. Conde-Agudelo,et al.  Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. , 1999, American journal of obstetrics and gynecology.

[84]  S. Sidney,et al.  A multivariate analysis of risk factors for preeclampsia. , 1991 .

[85]  W. Haynes,et al.  Leptin, obesity and cardiovascular disease , 2004, Current opinion in nephrology and hypertension.